JPRN-UMIN000035926已完成未知
An investigator-initiated clinical research on the ability of an electroencephalogram analysis program to differentiate between dementia with Lewy bodies (DLB) and Alzheimer's disease (AD) - An investigator-initiated clinical research on the ability of an electroencephalogram analysis program to differentiate between DLB and AD
Department of Behavioral Neurology and Neuropsychiatry, Osaka University United Graduate School of Child Development0 个研究点目标入组 40 人开始时间: 2019年3月11日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 50years-old 至 90years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Subject or responsible caregiver is unable or unwilling to give informed consent. 2)Presence of local or diffuse vascular lesions on MRI or CT, where this is thought to be the cause of, or contribute to the severity of the subject's dementia. 3)Suffering from a significant neurologic disease other than probable DLB or AD. 4)Systemic diseases possibly contributing to the severity of dementia. 5)History of alcohol or drug abuse or dependence within the past 2 years. 6)History of schizophrenia. 7)Any significant systemic illness or unstable medical condition that may affect EEG. 8)Use of specific medications: a)Centrally active beta-blockers (propranolol), methyldopa and clonidine within 4 weeks prior to screening, narcotics. b)Use of anti-Parkinsonism medications other than levodopacarbidopa, or levodopa benserazide within 4 weeks prior to screening. c)Neuroleptics or narcotic analgesics within 4 weeks prior to screening d)Long acting benzodiazepines or barbiturates within 4 weeks prior to screening e)Use of short-acting anxiolytics or sedative hypnotics more than 2 times per week within 4 weeks prior to screening. 9)Patients currently using memantine. Cholinesterase inhibitors are permitted if doses are stable for 4 weeks prior to screening. 10)Use of any investigational drugs within 30 days or 5 half lives prior to screening. 11)Subjects who, in the Principal Investigator's opinion, are unlikely to comply with the EEG recording procedure.
研究者
相似试验
进行中（未招募）
1 期
Investigator-initiated clinical research trial on the effects of 5% Minoxidil topical foam on gene expression, hair growth and scalp microenvironment in men with androgenetic alopeciaAndrogenetic Alopecia Hamilton-Norwood IIIv-IV male patientsMedDRA version: 16.1Level: PTClassification code 10068168Term: Androgenetic alopeciaSystem Organ Class: 10040785 - Skin and subcutaneous tissue disordersEUCTR2013-004130-15-DECharité-Universitätsmedizin Berlin, Department of Dermatology, Clinical Research Center for Hair and Skin Science12
招募中
Unknown
Investigator-initiated clinical trial of bradycardia with transvenous vagus nerve stimulation catheters for supraventricular tachyarrhythmiasAtrial fibrillation/Atrial flutter/Atrial tachycardia etc.JPRN-jRCT2072230062Sakamoto Kazuo20
进行中（未招募）
2 期
The safety and efficacy of ALARM-TD-V1 for sleep-disordered breathingSleep-disordered breathingD020181Obstructive Sleep Apnea SyndromeJPRN-jRCT2052230034Sato Susumu40
已完成
2 期
A clinical trial of a novel skin reconstruction treatment for GCMN.Congenital giant melanocytic nevusJPRN-jRCT2052210044Morimoto Naoki3
招募中
2 期
AllinOne-K-2JPRN-jRCT1080224639Takuya Takahashi10